Anxiolytic and Antidepressant Effects of Divaza and Brizantin
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605535264 | ||
| 003 | CHVBK | ||
| 005 | 20210128100846.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-3067-6 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-3067-6 | ||
| 245 | 0 | 0 | |a Anxiolytic and Antidepressant Effects of Divaza and Brizantin |h [Elektronische Daten] |c [N. Yakovleva, T. Voronina, N. Suslov, I. Ertuzun, G. Molodavkin, V. Poseva, V. Andreeva, Yu. Dugina, M. Putilovskii, O. Epshtein] |
| 520 | 3 | |a The anxiolytic and antidepressant activities of complex preparations divaza and brizantin containing antibodies to brain-specific protein S100 were estimated using Vogel conflict test and Nomura forced swimming test. Course treatment (5 days) of brizantin in a dose of 2.5 ml/kg and divaza in a dose of 7.5 ml/kg significantly increased punished drinking in the Vogel conflict test in comparison with the control. Both drugs also improved general emotional behavior during training prior to the test procedure. Brizantin and divaza in a dose of 7.5 ml/kg increased the number of wheel revolutions in the Nomura forced swimming test in comparison with the control; the effect of divaza was more pronounced. High correlation coefficients between the number of wheel revolutions during the first and second 5-min sessions are also indicative of antidepressant action of divaza and brizantin. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a divaza |2 nationallicence | |
| 690 | 7 | |a brizantin |2 nationallicence | |
| 690 | 7 | |a S100 |2 nationallicence | |
| 690 | 7 | |a anxiolytic effect |2 nationallicence | |
| 690 | 7 | |a antidepressant effect |2 nationallicence | |
| 700 | 1 | |a Yakovleva |D N. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Voronina |D T. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Suslov |D N. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Ertuzun |D I. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Molodavkin |D G. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Poseva |D V. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Andreeva |D V. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Dugina |D Yu |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Putilovskii |D M. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 700 | 1 | |a Epshtein |D O. |u Materia Medica Holding, Moscow, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/6(2015-10-01), 753-756 |x 0007-4888 |q 159:6<753 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-3067-6 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-3067-6 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yakovleva |D N. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Voronina |D T. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Suslov |D N. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ertuzun |D I. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Molodavkin |D G. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Poseva |D V. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Andreeva |D V. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Dugina |D Yu |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Putilovskii |D M. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Epshtein |D O. |u Materia Medica Holding, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/6(2015-10-01), 753-756 |x 0007-4888 |q 159:6<753 |1 2015 |2 159 |o 10517 | ||